Axos Financial, Inc.
NYSE:AXBanks - Regional
+$0.22 today
- Market cap
- $5.00B
- Beta
- 1.25
- P/E (TTM)
- 10.5
- EPS (TTM)
- $8.41
Volume 0.23M
Average 0.40M
AX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Axos Financial, Inc.NYSE: AX
Research & Development · Q4 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q4 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 0 | — |
| FY2025 | 2025-06-30 | 0 | — |
| FY2024 | 2024-06-30 | 0 | — |
| FY2023 | 2023-06-30 | 0 | — |
| FY2022 | 2022-06-30 | 0 | — |
Research & Development vs competitors
How AX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for AX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $47.52M USD | — | — | 1.1% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | PEN 0 PEN | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | COP 0 COP | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding AX) | — | — | — | 0.0% | |
Competitors are the stored peer set for AX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 757.91M | 1.26B | 1.77B | 1.93B | 2.19B |
| Cost of Revenue | 76.32M | 398.27M | 726.68M | 743.44M | 811.15M |
| Gross Profit | 681.59M | 865.93M | 1.04B | 1.19B | 1.38B |
| Gross Margin | 89.9% | 68.5% | 58.9% | 61.5% | 63.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 230.65M | 305.32M | 348.16M | 407.9M | 126.55M |
| Operating Expenses | 341.63M | 434.18M | 405.45M | 572.63M | 732.72M |
| Depreciation & Amortization | 24.6M | 23.39M | 27.09M | 29.02M | 80.62M |
| EBITDA | 364.56M | 455.13M | 662.57M | 642.41M | 727.29M |
| EBITDA Margin | 48.1% | 36.0% | 37.5% | 33.3% | 33.2% |
| Operating Income | 339.96M | 431.74M | 635.48M | 613.4M | 646.67M |
| Operating Margin | 44.9% | 34.2% | 36.0% | 31.8% | 29.5% |
| Interest Income | 659.73M | 1.16B | 1.66B | 1.82B | 1.96B |
| Interest Expense | 52.57M | 374.02M | 694.18M | 687.69M | 710.04M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 339.96M | 431.74M | 635.48M | 613.4M | 646.67M |
| Pre-Tax Margin | 44.9% | 34.2% | 36.0% | 31.8% | 29.5% |
| Income Tax Expense | 99.24M | 124.58M | 185.47M | 180.49M | 156.3M |
| Net Income | 240.72M | 307.17M | 450.01M | 432.91M | 490.37M |
| Net Margin | 31.8% | 24.3% | 25.5% | 22.4% | 22.4% |
| EPS (Basic) | 4.04 | 5.15 | 7.82 | 7.61 | 8.66 |
| EPS (Diluted) | 3.97 | 5.07 | 7.66 | 7.43 | 8.48 |
| Weighted Avg Shares | 59.52M | 59.69M | 57.51M | 56.86M | 56.66M |
| Weighted Avg Shares (Diluted) | 60.61M | 60.57M | 58.73M | 58.24M | 57.84M |
Axos Financial, Inc.
NYSE:AX
Intrinsic Alpha fair value
Locked
Current Price
$88.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.